starting dose of bpc 157 BPC-157 Dosage Chart – 10 mg Vial Protocol BPC-157 and TB-500 Dosing: Complete

3 Unlike many peptides that get broken down in the digestive tract, BPC-157 is not destroyed by stomach acid

Clinical experience suggests good tolerability, with: Mild injection site reactions Occasional digestive changes (particularly with oral administration) Rarely reported headache Important Safety Considerations Both peptides should be prescribed and monitored by qualified medical providers Quality of peptide sourcing matters compounding pharmacies should be licensed and regulated Lab monitoring (particularly IGF-1 for sermorelin) is essential for ongoing safety Contraindications (active malignancies, certain medical conditions) must be evaluated Medical Disclaimer Sermorelin was previously FDA-approved for diagnostic use (Geref Diagnostic) and is currently prescribed off-label through compounding pharmacies

Errors during reconstitution or storage directly impact effectiveness and safety

At this point, the doctor acknowledged that "in Australia peptides are very controversial" and that they "should be a last resort" and must only be prescribed for a legitimate medical condition

Disclosure of interest: Marc Rib: nothing to disclose